José Luis Fuster Selected Research

José Luis Fuster Research Topics

5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 12/2007
3	Leukemia 01/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2020
2	Cataract (Cataracts) 05/2021 - 01/2019
2	Hyperferritinemia 05/2021 - 01/2019
1	Bone Marrow Failure Disorders 10/2023
1	Residual Neoplasm 05/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023
1	Disease Progression 05/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Iron Overload 05/2021
1	hereditary Hyperferritinemia with congenital cataracts 05/2021
1	Rare Diseases (Rare Disease) 05/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2021
1	Neoplasms (Cancer) 01/2020
1	Iron Deficiencies 01/2019
1	Neurodegeneration with brain iron accumulation (NBIA) 01/2019
1	Neuroferritinopathy 01/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2018
1	Philadelphia Chromosome 12/2007

2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
2	Ferritins (Ferritin)IBA 05/2021 - 01/2019
1	Inosine Triphosphate (ITP)IBA 01/2022
1	AntigensIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	LigandsIBA 05/2021
1	Natural Killer Cell ReceptorsIBA 05/2021
1	KIR ReceptorsIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	ApoferritinsIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 12/2007

3	Hematopoietic Stem Cell Transplantation 10/2023 - 03/2018
3	Stem Cell Transplantation 01/2023 - 01/2020
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023 - 01/2020
2	Therapeutics 05/2023 - 01/2022
1	Splenectomy 01/2022
1	Transplantation 01/2020
1	Haploidentical Transplantation 01/2020
1	Drug Therapy (Chemotherapy) 12/2007